Table 1.
Sociodemographic, exposure risk, symptoms, and comorbidities of 44 individuals with SARS-CoV-2 by HIV status.
| Overall (N = 44) | PWH (N = 23) | HIV (-) (N = 21) | |
|---|---|---|---|
| Median age in years (Min, Max) | 48 (22, 78) | 55 (26, 68) | 36 (22, 78) |
| Race | |||
| Black | 6 (13.6) | 5 (23.8) | 1 (4.3) |
| White | 27 (61.4) | 11 (52.4) | 16 (69.6) |
| Native American | 1 (2.3) | 0 (0.0) | 1 (4.3) |
| Other | 10 (22.7) | 5 (23.8) | 5 (21.7) |
| Ethnicity | |||
| Hispanic | 37 (84.1) | 17 (81.0) | 20 (87.0) |
| Non-Hispanic | 4 (9.1) | 2 (9.5) | 2 (8.7) |
| Other | 3 (6.8) | 2 (9.5) | 1 (4.3) |
| Female | 20 (45.5) | 6 (28.6) | 14 (60.9) |
| Full/part-time employment | 23 (52.3) | 8 (38.1) | 15 (65.2) |
| Exposure risk | |||
| Healthcare worker | 10 (22.7) | 2 (9.5) | 8 (34.8) |
| Public transportation use | 11 (25.0) | 8 (38.1) | 3 (13.0) |
| Suspected contact with person with COVID-19 | 28 (63.6) | 12 (57.1) | 16 (69.6) |
| Absolute CD4+ T-cell count/μl, mean (± SD) | – | 772.10 (365.21) | – |
| SARS-CoV-2 diagnosis | |||
| Positive rapid test result at screening | 42 (97.7) | 20 (95.2) | 22 (100.0) |
| Mean time from positive PCR in days (± SD) | 15.11 (12.99) | 15.93 (13.85) | 11.00 (7.81) |
| Symptoms | |||
| Fever/elevated temperature | 24 (54.5) | 8 (38.1) | 12 (52.2) |
| Chills | 22 (50.0) | 13 (61.9) | 9 (39.1) |
| Muscle aches/myalgia | 35 (79.5) | 13 (61.9) | 22 (95.7) |
| Eye redness/conjunctivitis | 7 (15.9) | 4 (19.0) | 3 (13.0) |
| Upper respiratory tract* | 16 (36.4) | 10 (47.6) | 6 (26.1) |
| Dyspnea | 11 (25.0) | 5 (23.8) | 6 (26.1) |
| Confusion | 9 (20.5) | 5 (23.8) | 4 (17.4) |
| Headache | 32 (72.7) | 19 (82.6) | 13 (61.9) |
| Loss of taste/ageusia | 31 (70.5) | 14 (66.7) | 17 (73.9) |
| Loss of smell/anosmia | 32 (72.7) | 15 (71.4) | 17 (73.9) |
| Gastrointestinal symptoms** | 12 (27.3) | 5 (23.8) | 7 (30.4) |
| Concurrent symptoms | 34 (77.3) | 14 (66.7) | 20 (87.0) |
| Comorbidities | |||
| Cardiovascular disease risk*** | 1 (2.3) | 0 (0.0) | 1 (4.3) |
| Active malignancy | 3 (6.8) | 2 (9.5) | 1 (4.3) |
| Pulmonary disease | 5 (11.4) | 4 (19.0) | 1 (4.3) |
| Rheumatological disease | 2 (4.5) | 0 (0.0) | 2 (8.7) |
*
Upper Respiratory Tract Symptoms include runny nose, sore throat, or cough.
*
*Gastrointestinal Symptoms include Nausea/vomiting, diarrhea, or abdominal pain.
***
Cardiovascular Disease Risk includes Hypertension, Heart Disease, Diabetes Mellitus, and renal disease.
Data as presented as No. (%) unless otherwise indicated.